Pathkey.AI (ASX:PKY) — Material Events
ASX:PKY · 12 articles in the last 12 months · 100% assessed
Click a band to jump to that tier
Major ≥90
Significant 75–89
Notable 50–74
Routine <50
Not assessed
Pathkey.AI Completes Chipforge Acquisition to Expand AI Chip Design ReachMedium
Pathkey.AI completes acquisition of AI semiconductor design firm Chipforge
23 June 2026
·Acquisition Completion
·85
Pathkey.AI Secures $2.8M Placement with Sam Weiss as Strategic AdvisorMedium
Pathkey.AI appoints Sam Weiss as strategic advisor and raises $2.8 million placement
12 Aug 2026
·Capital Raising and Strategic Appointment
·85
Pathkey.AI Raises A$3.48m to Accelerate AI Growth with New Board LeadershipMedium
Pathkey.AI raises A$3.48m via placement and rights issue, appoints new chair to accelerate AI growth
27 Nov 2025
·Capital Raising
·80
Pathkey.AI Strengthens Board, Raises $3.5m to Expand AI Beyond HealthcareMedium
Pathkey.AI advances TrialKey platform, strengthens board, raises $3.5m to fuel AI growth beyond healthcare
30 Jan 2026
·Quarterly Report and Appendix 4C
·75
Pathkey Names Defence Tech Veteran Andrew Farnsworth as CEO to Accelerate AI GrowthMedium
Pathkey Appoints Andrew Farnsworth as CEO to Drive AI Platform Growth and Commercialisation
11 May 2026
·Executive Appointment
·75
Pathkey.AI Validates AI Platform and Revamps Board Amid Commercial PushMedium
Pathkey.AI validates AI platform, renews board, maintains financial discipline, and advances commercial growth
31 Oct 2025
·Quarterly Activities and Cash Flow Report
·75
How Pathkey.AI’s New Partnership Could Revolutionise Early-Phase Clinical TrialsMedium
Pathkey.AI and Armstrong Clinical Partner to Enhance Early-Phase Clinical Trial Success Using AI
12 Nov 2025
·Collaboration Agreement Announcement
·75
Pathkey.AI Launches $920K Rights Issue to Boost AI Growth and AcquisitionsMedium
Pathkey.AI launches $920K rights issue and $2.5M placement to fund AI growth and acquisitions
4 Dec 2025
·Capital Raising
·70
Pathkey.AI Lands A$100K Deal to Power Imunexus Clinical TrialsMedium
Pathkey.AI Secures A$100K Contract with Imunexus to Deploy AI TrialKey Platform
2 Apr 2026
·Commercial Contract Announcement
·70
PKY Adds Chip Design Expertise as Chipforge Moves Toward Commercial ReleaseMedium
Pathkey.AI appoints NTU chip design and AI expert to Chipforge Advisory Board
10 Sept 2026
·Advisory Board Appointment
·63
No articles in this tier for the last 12 months.
Market Mentions
9
- appeared in market wrap coverage
These are market wrap articles where Pathkey.AI (ASX:PKY) was mentioned. They reflect broader market coverage, not company-specific announcements.
Technology Wrap - Week 37 (7 Sept -> 11 Sept) 2026
12 Sept 2026
Technology Wrap - Week 33 (10 Aug -> 14 Aug) 2026
15 Aug 2026
Market Wrap - Week 26 (22 June -> 26 June) 2026
27 June 2026
Technology Wrap - Week 26 (22 June -> 26 June) 2026
27 June 2026
Technology Wrap - Week 25 (15 June -> 19 June) 2026
20 June 2026